<DOC>
	<DOCNO>NCT01293422</DOCNO>
	<brief_summary>This clinical trial design study effect pregnane X receptor activator rifampicin glucose , lipid hormone homeostasis healthy volunteer . The main hypothesis rifampicin raise postprandial glucose study oral glucose tolerance test . The study non-randomized , one-phase , open-label trial . Twelve subject give 600 mg rifampicin day week . The main outcome measure change glucose insulin level oral glucose tolerance test .</brief_summary>
	<brief_title>Effects Pregnane X Receptor ( PXR ) Activation Human Glucose , Lipid Hormone Homeostasis</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>Healthy volunteer Age 1845 year Body mass index 1928 Any continuous medication Any significant disease Allergy rifampicin Pregnancy breast feed Fear needle previous difficult blood sampling Substance abuse Participation another clinical drug trial within 1 month enrollment Use soft contact lens</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>PXR , glucose , cholesterol</keyword>
</DOC>